https://doi.org/10.1200/jco.22.01142
Y
Yihong Ling
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
84
Papers
2.1K
Citations
27
h-index
46
i10-index
Yihong Ling is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Gastric Cancer Management and Outcomes & Esophageal Cancer Research and Treatment. The author has an h-index of 27, co-authored 72 publications.
ORCID: 0000-0002-6433-3213Papers by this author
worksPostoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study
2022 · Journal of Clinical Oncology · 153 citations
Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma
2020 · BMC Cancer · 66 citations
https://doi.org/10.1186/s12885-020-07097-5
Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma
2019 · Journal of Biological Chemistry · 16 citations
https://doi.org/10.1074/jbc.ra119.008793
Indole-3-lactic acid protects the gut vascular barrier following intestinal ischemia injury through AhR/Nrf2/STAT3 mediated claudin 2 downregulation
2025 · Cell Communication and Signaling · 1 citations
https://doi.org/10.1186/s12964-025-02454-y
Explainable attention-enhanced heuristic paradigm for multi-view prognostic risk score development in hepatocellular carcinoma
2025 · Hepatology International · 0 citations
https://doi.org/10.1007/s12072-025-10793-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat